Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia

被引:10
|
作者
Yamamoto, Masaki [1 ]
Hori, Tsukasa [1 ]
Igarashi, Keita [1 ]
Shimada, Hiroyuki [2 ]
Tsutsumi, Hiroyuki [1 ]
机构
[1] Sapporo Med Univ, Dept Pediat, Sch Med, Sapporo, Hokkaido, Japan
[2] Keio Univ, Dept Pediat, Sch Med, Tokyo, Japan
关键词
childhood; Philadelphia chromosome-positive acute lymphoblastic leukemia; ponatinib; relapse; CHRONIC MYELOID-LEUKEMIA; MUTATION;
D O I
10.1111/ped.13437
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:85 / 87
页数:3
相关论文
共 50 条
  • [1] Response to ponatinib before hematopoietic stem cell transplantation in a child with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia (vol 60, pg 85, 2018)
    Yamamoto, Masaki
    Hori, Tsukasa
    Igarashi, Keita
    Shimada, Hiroyuki
    Tsutsumi, Hiroyuki
    PEDIATRICS INTERNATIONAL, 2018, 60 (03) : 322 - 322
  • [2] Monitoring Ponatinib in a Child with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Tanimura, Kazuki
    Yamasaki, Kai
    Okuhiro, Yuki
    Hira, Kota
    Nitani, Chika
    Okada, Keiko
    Fujisaki, Hiroyuki
    Matsumoto, Kana
    Hara, Junichi
    CASE REPORTS IN ONCOLOGY, 2021, 14 (01): : 24 - 28
  • [3] The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Sanford, David S.
    Kantarjian, Hagop
    O'Brien, Susan
    Jabbour, Elias
    Cortes, Jorge
    Ravandi, Farhad
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (04) : 365 - 373
  • [4] Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia
    Snyder, DS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) : 597 - 603
  • [5] Efficacy of Inotuzumab Ozogamicin plus Ponatinib Followed by Allogeneic Stem Cell Transplantation in a Patient with Relapsed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Micheva, Ilina
    Gerov, Vladimir
    Dimitrova, Stela
    Efraim, Merlin
    CASE REPORTS IN HEMATOLOGY, 2021, 2021
  • [6] Blinatumomab plus ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults
    Couturier, Marie-Anne
    Thomas, Xavier
    Raffoux, Emmanuel
    Huguet, Francoise
    Berthon, Celine
    Simand, Celestine
    Gallego-Hernanz, Maria-Pilar
    Hicheri, Yosr
    Berger, Mathilde Hunault
    Saillard, Colombe
    Leguay, Thibaut
    Loiseau, Clemence
    Bene, Marie-Christine
    Chevallier, Patrice
    LEUKEMIA & LYMPHOMA, 2021, 62 (03) : 620 - 629
  • [7] Salvage and bridging to allogeneic hematopoietic cell transplantation with ponatinib in patients with relapsed or refractory Philadelphia chromosome-positive leukemia
    Tachibana, Takayoshi
    Koyama, Satoshi
    Andou, Taiki
    Ishiyama, Yasufumi
    Tanaka, Masatsugu
    Nakajima, Hideaki
    Kanamori, Heiwa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (02) : 162 - 168
  • [8] Salvage and bridging to allogeneic hematopoietic cell transplantation with ponatinib in patients with relapsed or refractory Philadelphia chromosome-positive leukemia
    Takayoshi Tachibana
    Satoshi Koyama
    Taiki Andou
    Yasufumi Ishiyama
    Masatsugu Tanaka
    Hideaki Nakajima
    Heiwa Kanamori
    International Journal of Hematology, 2019, 109 : 162 - 168
  • [9] Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia
    Zerbit, Jeremie
    Tamburini, Jerome
    Goldwirt, Lauriane
    Decroocq, Justine
    Cayuela, Jean Michel
    Chapuis, Nicolas
    Contejean, Adrien
    Batista, Rui
    Bouscary, Didier
    Willems, Lise
    LEUKEMIA & LYMPHOMA, 2021, 62 (14) : 3558 - 3560
  • [10] The role of stem cell transplantation in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia
    Ribera, Jose-Maria
    Ribera, Jordi
    Genesca, Eulalia
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (12) : 357 - 368